MD3717F1 - Metoda de diagnostic diferentiat al tumorilor glandei mamare - Google Patents

Metoda de diagnostic diferentiat al tumorilor glandei mamare Download PDF

Info

Publication number
MD3717F1
MD3717F1 MDA20080082A MD20080082A MD3717F1 MD 3717 F1 MD3717 F1 MD 3717F1 MD A20080082 A MDA20080082 A MD A20080082A MD 20080082 A MD20080082 A MD 20080082A MD 3717 F1 MD3717 F1 MD 3717F1
Authority
MD
Moldova
Prior art keywords
g6pdh
gsh
gst
ggt
saliva
Prior art date
Application number
MDA20080082A
Other languages
English (en)
Other versions
MD3717G2 (ro
Inventor
Ludmila Gavriliuc
Nadejda Godoroja
Natalia Botnariuc
Ana Vartician
Original Assignee
Universitatea De Stat De Medicina Si Farmacie "Nicolae Testemitanu" Din Republica Moldova
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Universitatea De Stat De Medicina Si Farmacie "Nicolae Testemitanu" Din Republica Moldova filed Critical Universitatea De Stat De Medicina Si Farmacie "Nicolae Testemitanu" Din Republica Moldova
Priority to MDA20080082A priority Critical patent/MD3717G2/ro
Publication of MD3717F1 publication Critical patent/MD3717F1/ro
Publication of MD3717G2 publication Critical patent/MD3717G2/ro

Links

Landscapes

  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

Inventia se refera la medicina, si anume la biochimia clinica si poate fi utilizata pentru diagnosticarea diferentiata a hiperplaziilor dishormonale si a cancerului glandei mamare. Esenta inventiei consta in aceea ca se determina continutul glutationului redus (GSH), activitatea glutation-S-transferazei (GST), glutationreductazei (GR), gama-glutamiltranspeptidazei (GGT) si glucozo-6-fosfatdehidrogenazei (G6PDH) in plasma sangelui si in saliva, se calculeaza raporturile GR/G6PDH, GR/GST, GR/GGTsi GR/GSH si in cazul in care in plasma se determina: GR/G6PDH de la 1,89 la 2,94; GR/GST de la 0,41 la 0,54; GR/GGT de la 4,83 la 8,70; GR/GSH de la333,0 la 454,0; iar in saliva: GR/G6PDH de la 1,41 la 2,21; GR/GST de la 0,34 la 0,42; GR/GGT de la1,62 la 2,59; GR/GSH de la 613,0 la 663,2 se diagnosticheaza hiperplazie dishormonala a glandei mamare, iar in cazul in care in plasma se determina:GR/G6PDH de la 0,84 la 1,89; GR/GST de la 0,29 la0,41; GR/GGT de la 0,96 la 4,83; GR/GSH de la 212,0 la 333,0; iar in saliva: GR/G6PDH de la 0,61 la1,41; GR/GST de la 0,26 la 0,34; GR/GGT de la 0,65 la 1,62; GR/GSH de la 562,8 la 613,0 se diagnosticheaza cancer al glandei mamare.
MDA20080082A 2008-03-21 2008-03-21 Metodă de diagnostic diferenţiat al tumorilor glandei mamare MD3717G2 (ro)

Priority Applications (1)

Application Number Priority Date Filing Date Title
MDA20080082A MD3717G2 (ro) 2008-03-21 2008-03-21 Metodă de diagnostic diferenţiat al tumorilor glandei mamare

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
MDA20080082A MD3717G2 (ro) 2008-03-21 2008-03-21 Metodă de diagnostic diferenţiat al tumorilor glandei mamare

Publications (2)

Publication Number Publication Date
MD3717F1 true MD3717F1 (ro) 2008-10-31
MD3717G2 MD3717G2 (ro) 2009-05-31

Family

ID=40030517

Family Applications (1)

Application Number Title Priority Date Filing Date
MDA20080082A MD3717G2 (ro) 2008-03-21 2008-03-21 Metodă de diagnostic diferenţiat al tumorilor glandei mamare

Country Status (1)

Country Link
MD (1) MD3717G2 (ro)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MD492Z (ro) * 2011-08-17 2012-10-31 Лорена МЕДНИКОВ Metodă de determinare a răspândirii cancerului gastric de tip intestinal

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SU873504A1 (ru) * 1972-10-31 1982-04-30 Ростовский научно-исследовательский онкологический институт Способ диагностики рака молочной железы
SU683049A1 (ru) * 1977-04-19 1982-11-30 Латвийский Научно-Исследовательский Институт Экспериментальной И Клинической Медицины Способ диагностики рака молочной железы
SU919178A1 (ru) * 1980-10-10 1988-02-07 Институт Проблем Передачи Информации Ан Ссср Способ рентгенодиагностики рака молочной железы
SU1114004A1 (ru) * 1981-12-29 1988-06-07 1-Й Ленинградский Медицинский Институт Им.Акад.Н.П.Павлова Способ диагностики степени малигнизации при фиброзно-кистозной мастопатии
SU1349498A1 (ru) * 1984-04-28 1991-08-30 Одесский Медицинский Институт Им.Н.И.Пирогова Способ диагностики метастазов рака молочной железы в лимфоузлы

Also Published As

Publication number Publication date
MD3717G2 (ro) 2009-05-31

Similar Documents

Publication Publication Date Title
KR102604096B1 (ko) 윌슨병을 치료하기 위한 유전자 치료
Zhang et al. Non-invasive detection of gastric cancer relevant d-amino acids with luminescent DNA/silver nanoclusters
Ang et al. Human papillomavirus as a marker of the natural history and response to therapy of head and neck squamous cell carcinoma
Frost Physiological functions of the alpha class of carbonic anhydrases
Gillmor et al. The structure of mammalian 15-lipoxygenase reveals similarity to the lipases and the determinants of substrate specificity
ES2906361T3 (es) Anticuerpos biespecíficos para ROR1 y CD3
Stansfield et al. Periostin is a novel factor in cardiac remodeling after experimental and clinical unloading of the failing heart
Thiel et al. Expression of cyclooxygenase-2 is regulated by glycogen synthase kinase-3β in gastric cancer cells
Abraham et al. Diastolic dysfunction in familial hypertrophic cardiomyopathy transgenic model mice
UA109633C2 (uk) Антитіло людини проти тканинного фактора
Qin et al. Maintenance of androgen receptor inactivation by S-nitrosylation
Liu et al. High expression of synthesis of cytochrome c oxidase 2 and TP53-induced glycolysis and apoptosis regulator can predict poor prognosis in human lung adenocarcinoma
Li et al. Association between circulating angiotensin-converting enzyme 2 and cardiac remodeling in hypertensive patients
EP2534168A4 (en) CHEMICAL PREPARATION OF UBIQUITINTHIOESTERN AND MODIFICATIONS THEREOF
Dong et al. Secretory phospholipase A2-IIa upregulates HER/HER2-elicited signaling in lung cancer cells
MD3717F1 (ro) Metoda de diagnostic diferentiat al tumorilor glandei mamare
Attanasio et al. Extramedullary plasmacytoma of paranasal sinuses. A combined therapeutic strategy
WO2009019369A3 (fr) Procede de dosage de la plastine-i pour le diagnostic in vitro du cancer colorectal
WO2009091230A3 (ko) 유방암 모니터링,진단 및 스크리닝용 단백질 마커 및 이를 이용한 유방암 모니터링,진단 및 스크리닝 방법
EP1825261A4 (en) DIAGNOSIS OF CONDITIONS ASSOCIATED WITH REDUCED BIODAVAILABILITY OF ARGININE
Dave et al. An inhibitor-like binding mode of a carbonic anhydrase activator within the active site of isoform II
WO2011109285A3 (en) Prognostic marker for cryoglobulinemic vasculitis and b cell malignancies in hcv infected patients
Otsuka et al. Androgen receptor W741C and T877A mutations in AIDL cells, an androgen-independent subline of prostate cancer LNCaP cells
WO2010126338A3 (ko) 유방암 진단용 바이오마커 및 유방암 진단제
Ozkan et al. Serum Angiotensin II as a Biomarker in COVID-19

Legal Events

Date Code Title Description
FG4A Patent for invention issued
KA4A Patent for invention lapsed due to non-payment of fees (with right of restoration)
MM4A Patent for invention definitely lapsed due to non-payment of fees